Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-03001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-462 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 |
filingDate |
2017-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2019-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2019513711-A |
titleOfInvention |
Treating muscle weakness with alkaline phosphatase |
abstract |
The present disclosure includes the treatment of at least one symptom of said subject having or prone to a muscle weakness disease comprising administering to the subject a therapeutically effective amount of at least one recombinant polypeptide having alkaline phosphatase activity. It features a way to improve or improve. [Selected figure] Figure 1 |
priorityDate |
2016-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |